Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Insulin for Corneal Healing Post-PRK
NCT06956846Phase 4Not yet recruiting
- Sponsor
- Hôtel-Dieu de France
- Start
- Apr 2025
- Primary completion
- Jun 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of regular human insulin in Corneal epithelial defect, sponsored by Hôtel-Dieu de France. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
regular human insulin
03
Conditions
Corneal epithelial defect
Beyond the preview
Go deeper on NCT06956846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06956846.